Get the Stockscreener App
1.21
3.42%
0.04
After Hours:
1.23
0.02
+1.65%
Windtree Therapeutics Inc Stock (WINT) Forecast
The Windtree Therapeutics Inc (WINT) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.50, representing a +23.97% increase from the current price of $1.21. The highest analyst price target is $2.7784, and the lowest is $0.2216.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month WINT Price Target
Average 1.5293
(+26.39% Upside)
Is Windtree Therapeutics Inc (WINT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.17 | Neutral |
| STOCH(9,6) | 25.47 | Neutral |
| STOCHRSI(14) | 80.25 | Sell |
| MACD(12,26) | -0.1218 | Buy |
| ADX(14) | 22.12 | Neutral |
| William %R | -58.33 | Neutral |
| CCI(14) | -4.7966 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.182
Buy
|
1.191
Buy
|
| MA20 |
1.245
Sell
|
1.2877
Sell
|
| MA50 |
1.6824
Sell
|
1.348
Sell
|
| MA100 |
0.9799
Buy
|
1.4007
Sell
|
| MA200 |
2.4881
Sell
|
1.5475
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, WINT could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 8 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on WINT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.17 indicates that WINT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 25.47 indicates that WINT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 80.25 indicates that WINT is oversold. This suggests that WINT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.12 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -4.7966 indicates that WINT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term WINT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Windtree Therapeutics Inc financial reports and earnings history, Windtree Therapeutics Inc (WINT) stock could reach $3.9054 by 2030, $10.02 by 2040 and $25.75 by 2050. See the projected annual prices until 2050 of the Windtree Therapeutics Inc stock below:
- Windtree Therapeutics Inc (WINT) is expected to reach an average price of $5.9687 in 2035, with a high prediction of $5.9979 and a low estimate of $5.9932. This indicates an $393.28% rise from the last recorded price of $1.21.
- Windtree Therapeutics Inc (WINT) stock is projected to chart a bullish course in 2040, with an average price target of $10.61, representing an $776.89% surge from its current level. The forecast ranges from a conservative $7.7982 to a sky-high $10.02.
- Our analysts predict Windtree Therapeutics Inc (WINT) to jump 1,429% by 2045, soaring from $18.51 to an average price of $18.50, potentially reaching $18.61. While $18.51 is the low estimate, the potential upside is significant.
- Windtree Therapeutics Inc (WINT) stock is expected to climb by 2050, reaching an average of $25.51, a $2,008% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.75 and $25.65, respectively, highlighting the market's uncertainty.
Windtree Therapeutics Inc Stock (WINT) Year by Year Forecast
Windtree Therapeutics Inc Stock (WINT) Price Forecast for 2025
Windtree Therapeutics Inc Stock (WINT) is expected to reach an average price of $3.658 in 2025, with a high prediction of $7.25 and a low estimate of $0.0659. This indicates an +202.31% rise from the last recorded price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $2.5157 | $0.2216 | $2.7784 | +107.91% |
| June, 2025 | $2.2403 | $2.2403 | $2.5716 | +85.15% |
| July, 2025 | $0.2665 | $0.3524 | $2.2089 | -77.98% |
| August, 2025 | $0.3219 | $0.2192 | $0.5922 | -73.40% |
| September, 2025 | $2.0895 | $0.0659 | $2.9927 | +72.69% |
| October, 2025 | $0.374 | $0.5177 | $2.3499 | -69.09% |
| November, 2025 | $1.3994 | $0.3681 | $1.8506 | +15.66% |
| December, 2025 | $0.5462 | $0.3948 | $1.0108 | -54.86% |
Windtree Therapeutics Inc Stock (WINT) Price Forecast for 2026
The predicted value for Windtree Therapeutics Inc (WINT) in 2026 is set at an average of $2.4205. Estimates vary from a peak of $4.3781 to a trough of $0.4629, indicating an +100.04% surge from the present price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.0416 | $0.5502 | $0.1089 | -96.56% |
| February, 2026 | $0.937 | $0.4629 | $0.257 | -22.56% |
| March, 2026 | $0.7024 | $1.3424 | $0.761 | -41.95% |
| April, 2026 | $0.9192 | $1.0081 | $0.7892 | -24.04% |
| May, 2026 | $2.4146 | $1.5105 | $2.1632 | +99.55% |
| June, 2026 | $3.95 | $3.9386 | $3.8773 | +226.44% |
| July, 2026 | $4.4867 | $4.104 | $4.1167 | +270.80% |
| August, 2026 | $3.7521 | $3.9421 | $4.3781 | +210.09% |
| September, 2026 | $3.9289 | $3.8962 | $3.8789 | +224.70% |
| October, 2026 | $4.1843 | $4.1943 | $4.0916 | +245.81% |
| November, 2026 | $3.9697 | $4.0997 | $4.168 | +228.07% |
| December, 2026 | $3.8064 | $3.9964 | $3.9337 | +214.58% |
Windtree Therapeutics Inc Stock (WINT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Windtree Therapeutics Inc (WINT) is $18.45, with a high forecast of $33.33 and a low forecast of $3.5605. This indicates an +1,425% increase from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.8818 | $3.5605 | $3.7078 | +220.81% |
| February, 2027 | $4.1272 | $3.9739 | $3.8972 | +241.10% |
| March, 2027 | $3.964 | $3.9935 | $3.944 | +227.60% |
| April, 2027 | $4.0294 | $4.0554 | $3.9851 | +233.01% |
| May, 2027 | $4.1748 | $4.2008 | $4.3035 | +245.03% |
| June, 2027 | $4.3316 | $4.3402 | $4.3089 | +257.98% |
| July, 2027 | $4.137 | $4.237 | $4.2729 | +241.90% |
| August, 2027 | $4.3926 | $4.1783 | $4.121 | +263.02% |
| September, 2027 | $4.6541 | $4.4624 | $33.33 | +284.64% |
| October, 2027 | $4.6519 | $4.6159 | $4.5906 | +284.46% |
| November, 2027 | $4.5089 | $4.5499 | $4.5609 | +272.64% |
| December, 2027 | $4.4697 | $4.5167 | $4.5026 | +269.40% |
Windtree Therapeutics Inc Stock (WINT) Price Forecast for 2028
In 2028, Windtree Therapeutics Inc (WINT) is projected to reach an average price of $7.2313, with a high projection of $14.38 and a low estimate of $0.0847. This indicates an +497.63% rise from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.3891 | $4.4056 | $4.438 | +262.74% |
| February, 2028 | $4.4174 | $4.3865 | $4.3812 | +265.07% |
| March, 2028 | $4.4528 | $4.4089 | $4.4345 | +268.00% |
| April, 2028 | $4.375 | $4.3946 | $4.4211 | +261.57% |
| May, 2028 | $4.2864 | $4.2953 | $4.3225 | +254.25% |
| June, 2028 | $4.2198 | $4.2105 | $4.2628 | +248.75% |
| July, 2028 | $4.1513 | $4.1572 | $4.181 | +243.08% |
| August, 2028 | $0.406 | $0.206 | $8.4401 | -66.44% |
| September, 2028 | $0.7606 | $0.0847 | $3.342 | -37.14% |
| October, 2028 | $2.4548 | $0.2093 | $14.38 | +102.88% |
| November, 2028 | $2.5815 | $2.5761 | $2.68 | +113.35% |
| December, 2028 | $2.6469 | $2.4842 | $2.5169 | +118.76% |
Windtree Therapeutics Inc Stock (WINT) Price Forecast for 2029
The 2029 price forecast for Windtree Therapeutics Inc Stock (WINT) is $2.6371 on average, with a high prediction of $3.86 and a low estimate of $1.4141. This represents an +117.94% increase from the previous price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.4137 | $2.4337 | $2.5583 | +99.48% |
| February, 2029 | $2.6691 | $2.4564 | $2.4291 | +120.59% |
| March, 2029 | $2.5045 | $2.5918 | $2.5605 | +106.98% |
| April, 2029 | $2.3299 | $2.4799 | $2.5672 | +92.56% |
| May, 2029 | $2.4882 | $2.3913 | $2.474 | +105.63% |
| June, 2029 | $2.3621 | $2.4107 | $2.468 | +95.21% |
| July, 2029 | $2.6185 | $2.6408 | $2.5941 | +116.40% |
| August, 2029 | $2.8239 | $2.7188 | $2.7852 | +133.38% |
| September, 2029 | $2.852 | $2.8383 | $2.8078 | +135.70% |
| October, 2029 | $2.7164 | $2.7364 | $2.7755 | +124.50% |
| November, 2029 | $2.66 | $2.6694 | $2.6897 | +119.83% |
| December, 2029 | $3.92 | $1.4141 | $3.86 | +223.97% |
Windtree Therapeutics Inc Stock (WINT) Price Forecast for 2030
Windtree Therapeutics Inc Stock (WINT) is expected to reach an average price of $4.5986 in 2030, with a high forecast of $6.4757 and a low forecast of $2.7216. This signifies an +280.05% surge from the last price of $1.21.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.5335 | $3.1335 | $3.9054 | +109.38% |
| February, 2030 | $2.6843 | $2.7216 | $2.7216 | +121.84% |
| March, 2030 | $4.0951 | $4.747 | $4.0351 | +238.44% |
| April, 2030 | $4.1559 | $4.5532 | $4.5605 | +243.47% |
| May, 2030 | $4.0294 | $4.0067 | $4.5086 | +233.01% |
| June, 2030 | $5.6503 | $6.4748 | $5.5603 | +366.96% |
| July, 2030 | $6.0938 | $6.4757 | $6.4757 | +403.62% |
| August, 2030 | $5.0146 | $3.5892 | $4.3019 | +314.43% |
| September, 2030 | $2.7654 | $2.8027 | $3.4773 | +128.54% |
| October, 2030 | $2.8789 | $3.5835 | $2.8789 | +137.92% |
| November, 2030 | $3.7797 | $4.087 | $3.1797 | +212.37% |
| December, 2030 | $4.9805 | $5.4305 | $5.0178 | +311.61% |
0.24%
36.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):